Most mutations which cause disease by swapping one amino acid out for another do so by making the protein less stable, ...

Researchers eventually want to map the effects of every possible mutation on all human proteins to transform precision ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia.

By one estimate, 68% of Americans consume less than the recommended dietary amount of magnesium. Magnesium is essential for ...

Most mutations which cause disease by swapping one amino acid out for another do so by making the protein less stable, ...

Current data suggest men and women may experience stress differently, highlighting the need for personalized stress ...

The market is flooded with calming aids for cats and dogs, but what about our more exotic pets? Stress manifests differently ...

Here's a breakdown of how NeuroQuiet works, one ingredient at a time: ...